Related Experiment Videos
Beneficial effect of preoperative mycophenolate mofetil in murine corneal transplantation
A Reis1, H Spelsberg, T Reinhard
1Eye Clinic, Heinrich-Heine University, Moorenstr. 5, D-40 225 Duesseldorf, Germany. reis@uni-duesseldorf.de
Abstract:
To investigate the effect of preoperative mycophenolate mofetil (MMF) on allograft survival in a murine corneal transplantation model. Corneal grafting was performed from Brown Norway to Lewis rats. Groups were divided as follows: Rats that received syngeneic or allogeneic grafts without therapy served as controls. MMF treatment was either started 7 days prior to transplantation and continued for 14 postoperative days (POD) or started at the day of corneal grafting until POD 14. MMF (20 mg/kg) administered postoperatively had no significant beneficial effect on corneal graft survival when compared with controls. However, the group receiving 40 mg/kg MMF postoperatively showed a statistically significant prolonged graft survival. A 1-week preoperative administration of 20 mg/kg MMF allowed superior graft survival. Priming the immune system of corneal transplant recipients preoperatively with MMF proved to be a beneficial therapeutic regimen for prolonging corneal allograft survival in rats.
Insights
Preoperative administration of mycophenolate mofetil (MMF) significantly improved corneal allograft survival in rats. Postoperative MMF showed benefits only at higher doses, suggesting a superior preoperative immune priming strategy.
Area of Science:
- Immunology
- Ophthalmology
- Transplantation Science
Background:
- Corneal transplantation is crucial for vision restoration.
- Allograft rejection remains a significant challenge in corneal grafting.
- Immunosuppressive agents are vital for preventing graft rejection.
Purpose of the Study:
- To evaluate the efficacy of mycophenolate mofetil (MMF) in improving corneal allograft survival.
- To compare the effects of preoperative versus postoperative MMF administration.
- To determine the optimal timing and dosage of MMF for corneal transplantation.
Main Methods:
- Corneal transplantation was performed in a rat model (Brown Norway to Lewis rats).
- Groups received syngeneic or allogeneic grafts without therapy (controls).
- MMF was administered either preoperatively (7 days prior) or postoperatively (starting day of surgery), continuing for 14 days.
Main Results:
- Postoperative MMF at 20 mg/kg showed no significant benefit compared to controls.
- A higher dose of 40 mg/kg MMF postoperatively significantly prolonged graft survival.
- Preoperative administration of 20 mg/kg MMF for one week resulted in superior graft survival.
Conclusions:
- Preoperative immune modulation with MMF is a beneficial strategy for enhancing corneal allograft survival.
- Timing of MMF administration is critical, with preoperative treatment showing greater efficacy.
- MMF holds promise as an effective immunosuppressant for corneal transplantation in preclinical models.